Patent · US Active

Simultaneous quantification of nucleic acids in diseased cells

US7919247B2 · kind B2 · utility

27Cited by
10References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 3, 2007
Grant dateApr 5, 2011
Priority date
Expiry dateOct 16, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/81
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A process for assessing mitochondrial toxicity of a compound that includes contacting nucleic acids from a host with an amplification reaction mixture that contains at least two primers that provide detectable signals, wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.